by Cari Sass for Chain Drug Review January 5, 2015 In a multipart series during 2014 our team has examined key product attributes and marketing tactics from two different perspectives — the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In our final … Read More
Meeting-ful vs. Meaningful?
by Dave Wendland, as seen in Healthcare Distributor magazine, Out of the Box column January/February 2015 Recently, our art director commented that he no longer plans to attend meetings that are not meaningful. It reminded me of a frustration that my father once shared many years ago when he stated, “Meetings with an outcome focused … Read More
Rub some dirt on it
by Dave Wendland, as seen in Healthcare Distributor magazine, Out of the Box column December 2014/January 2015 Although I don’t actually recall my father or mother ever using the phrase, “Rub some dirt on it,” I’m sure many readers can attest to such encouragements. Honestly, I haven’t heard it lately, and admittedly, I never encouraged my own children to … Read More
Shopper “in” sites
By Dave Wendland for Drug Store News January 8, 2015 It wasn’t terribly long ago that a merchant could literally locate a storefront, hang a shingle, stock some merchandise, and claim themselves a retailer. Oh my how times have changed. There are many “in” sites to be considered. This post serves to examine where today’s shopping … Read More
In brand marketing, relevance to consumer is critical
by Jenny Kosek for Chain Drug Review December 9, 2014 In a multipart series during 2014, our team is examining key product attributes and marketing tactics from two different perspectives — the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, … Read More
Where’d that come from?
by Dave Wendland, as seen in Healthcare Distributor magazine, Out of the Box column October/November 2014 It’s the law On November 27, 2013, President Obama signed into law the Drug Quality and Security Act (DQSA), which amends the Federal Food, Drug, and Cosmetic Act. Title II of this law establishes a timeline for entities involved in the pharmaceutical distribution … Read More
Industry eVENTS
by Dave Wendland, as seen in Healthcare Distributor magazine, Out of the Box column August/September 2014 I was recently pondering whether it would be possible to achieve the same level of industry connectivity and productivity if annual industry events were conducted via the Internet? In other words, sponsoring organizations would host eVENTS. Having attended a series of events … Read More
e-OTC Concept Can Aid in Rx-to-OTC Switches
As seen in Pharmacy Times September 12, 2014 As more prescription products make the switch to OTC status, pharmacists and patients may see a new option for ensuring optimal treatment: the e-OTC drug. The e-OTC drug concept has its roots in a 2012 FDA initiative regarding prescription-to-OTC switches. The initiative, called the Non-Prescription, Safe-Use, Regulatory Expansion (NSURE), … Read More
Product attributes impact buyers, shoppers
by Jenny Kosek for Chain Drug Review August 25, 2014 In a multipart series during 2014, our team will examine key product attributes and marketing tactics from two different perspectives — the retail buyer and the consumer/shopper. We believe readers will benefit from an objective picture of the viewpoints that contribute to a product’s success … Read More
Standing room only
by Dave Wendland, as seen in Healthcare Distributor magazine, Out of the Box column April/May 2014 One of life’s annoyances I have little patience for is the recorded message I receive when phoning a cable company or utility: “Due to unexpected call volumes, we are experiencing extended wait times. Your call is important to us and we appreciate your … Read More